REDEFINE (obesity) and REIMAGINE (T2D) are the main Phase 3 programs, with REDEFINE 1, 2, and 4 already reported
Join Vumedi Select specialty Your main specialty Adult & Family Medicine Allergy, Asthma, Immunology Anesthesiology Cardiology Dental Dermatology Emergency Medicine Endocrinology Gastroenterology & Hepatology General Surgery Hematology & Oncology Infectious Disease Medical Genetics Nephrology Neurology Neurosurgery Obstetrics/Gynecology Ophthalmology Oral Maxillofacial Orthopaedics Otolaryngology Pathology Pediatrics Physical Medicine & Rehab Plastic Surgery Podiatry Preventive Medicine Psychiatry Pulmonology Radiation Oncology Radiology Rheumatology Urology First name Last name Email Choose Password
What Now
If so, this information may be relevant for you
Stancic-Rokotov D, Balenovic D, Udovicic M, et al
At 2.5 mg/mL, that same dose requires just 96 units, fitting comfortably in a 1 mL syringe